We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
+6.67%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$133B
AUM Growth
+$12.2B
Cap. Flow
+$7.34B
Cap. Flow %
5.51%
Top 10 Hldgs %
31.59%
Holding
1,470
New
67
Increased
946
Reduced
372
Closed
66

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.09B
2
AEM icon
Agnico Eagle Mines
AEM
+$830M
3
AVGO icon
Broadcom
AVGO
+$763M
4
NEM icon
Newmont
NEM
+$717M
5
TSM icon
TSMC
TSM
+$618M

Sector Composition

Rank Sector Weight
1 Technology 41.47%
2 Materials 28.65%
3 Industrials 6.66%
4 Energy 5.06%
5 Healthcare 4.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBLA icon
1251
Taboola.com
TBLA
$1.34B
$223K ﹤0.01%
71,966
+10,373
+17% +$37.1K
INSP icon
1252
Inspire Medical Systems
INSP
$1.45B
$219K ﹤0.01%
4,242
+2,228
+111% +$156K
KRNT icon
1253
Kornit Digital
KRNT
$707M
$218K ﹤0.01%
14,888
+2,146
+17% +$31.4K
PFG icon
1254
Principal Financial Group
PFG
$23.4B
$218K ﹤0.01%
2,423
+112
+5% +$10.2K
SAFE
1255
Safehold
SAFE
$1.19B
$214K ﹤0.01%
15,826
+819
+5% +$12.1K
ATEC icon
1256
Alphatec Holdings
ATEC
$1.24B
$211K ﹤0.01%
19,354
+8,036
+71% +$117K
DTE icon
1257
DTE Energy
DTE
$30.9B
$211K ﹤0.01%
1,442
-294
-17% -$41.3K
TMDX icon
1258
Transmedics
TMDX
$2.46B
$206K ﹤0.01%
2,072
+288
+16% +$37.6K
PRCT icon
1259
Procept Biorobotics
PRCT
$1.01B
$205K ﹤0.01%
8,202
+2,259
+38% +$63.7K
SRAD icon
1260
Sportradar
SRAD
$4.22B
$200K ﹤0.01%
11,927
-3,700
-24% -$68.8K
HBAN icon
1261
Huntington Bancshares
HBAN
$37B
$192K ﹤0.01%
12,280
+569
+5% +$9.72K
KEY icon
1262
KeyCorp
KEY
$24.9B
$191K ﹤0.01%
9,512
+442
+5% +$9.26K
BEN icon
1263
Franklin Resources
BEN
$16.8B
$186K ﹤0.01%
7,891
-629
-7% -$16.2K
PTCT icon
1264
PTC Therapeutics
PTCT
$6.5B
$184K ﹤0.01%
2,700
-162
-6% -$11.5K
OPK icon
1265
Opko Health
OPK
$891M
$183K ﹤0.01%
160,096
+23,077
+17% +$28.4K
FOLD
1266
DELISTED
Amicus Therapeutics
FOLD
$182K ﹤0.01%
12,573
+447
+4% +$6.41K
SUPV
1267
Grupo Supervielle
SUPV
$896M
$178K ﹤0.01%
18,866
+9,601
+104% +$98.5K
LOMA
1268
Loma Negra
LOMA
$1.42B
$177K ﹤0.01%
15,957
+7,927
+99% +$88.6K
VINP icon
1269
Vinci Compass Investments Ltd
VINP
$630M
$174K ﹤0.01%
16,466
+1,771
+12% +$21.2K
HLT icon
1270
Hilton Worldwide
HLT
$73.8B
$171K ﹤0.01%
+561
New +$170K
UAL icon
1271
United Airlines
UAL
$38.1B
$171K ﹤0.01%
1,861
+86
+5% +$9.01K
SSYS icon
1272
Stratasys
SSYS
$713M
$169K ﹤0.01%
21,665
+2,190
+11% +$21.4K
ODD icon
1273
ODDITY Tech
ODD
$756M
$167K ﹤0.01%
12,487
+1,799
+17% +$45.1K
IRTC icon
1274
iRhythm Holdings
IRTC
$3.49B
$166K ﹤0.01%
1,407
+5
+0.4% +$722
STKL
1275
DELISTED
SunOpta
STKL
$164K ﹤0.01%
25,297
+859
+4% +$4.86K

Similar funds

VanEck Associates's Q1 2026 Portfolio in Review

As of Q1 2026, VanEck Associates held 1,470 positions worth $133B, up 10% from $121B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

VanEck Associates deployed $7.34B of net new capital in Q1 2026, opening 67 new positions and adding to 946 existing holdings. Its largest new stake was United States Antimony: 10,369,695 shares worth $90.5M.

By sector, the portfolio is most concentrated in Technology at 41% of assets, down from 42% a quarter earlier, followed by Materials and Industrials.

On the sell side, the largest reduction was Pan American Silver, an estimated $1.04B trimmed.

  • VanEck Associates's largest Q1 2026 buy was United States Antimony: 10,369,695 shares worth $90.5M.
  • VanEck Associates added most to NVIDIA in Q1 2026, an estimated $1.09B increase.
  • VanEck Associates's biggest Q1 2026 reduction was Pan American Silver, cutting an estimated $1.04B.
  • VanEck Associates fully exited Ur-Energy in Q1 2026, selling an estimated $28.4M.
  • VanEck Associates's ten largest holdings make up 32% of its $133B portfolio in Q1 2026.
  • VanEck Associates opened 67 new positions and closed 66 in Q1 2026.
  • VanEck Associates's portfolio value rose 10% quarter-over-quarter to $133B.

Based on VanEck Associates's 13F filing for Q1 2026, filed 15 May 2026.